Skip to main content

Table 5 CT scan measurements of changes in volume, luminal area and airway wall thickness with sulforaphane (SF) treatment measured at either total lung capacity (TLC) or functional residual capacity (FRC) (mean ± SD)

From: Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways

 

Before SF

After SF

p for SF effect

TLC lung volume (mL)

4175

4195

0.68

FRC lung volume (mL)

1470

1647

0.44

Mean lung density at TLC (HU)

−820 ± 34

−823 ± 33

0.13

Air trapping (%) (FRC)

4.6 ± 8.3

7.9 ± 11.8

0.10

Airway luminal area (TLC) mm2

44.7 ± 10.3

45.1 ± 8.5

0.07

Large

103 ± 13

102.9 ± 16

0.73

Medium

30.9 ± 1.8

32 ± 4.5

0.04

Small

13.1 ± 1.6

14.3 ± 3.4

0.01

Airway wall thickness (fraction luminal diameter) (TLC)

0.57 ± 0.03

0.57 ± 0.02

0.82

Large

0.45 ± 0.02

0.46 ± 0.03

0.12

Medium

0.58 ± 0.02

0.58 ± 0.03

0.96

Small

0.67 ± 0.02

0.66 ± 0.04

0.03